Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma
Crossref DOI link: https://doi.org/10.1007/s11060-024-04666-7
Published Online: 2024-04-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wilson, Liam http://orcid.org/0009-0008-1439-6911
Atallah, Aline
Romero, Joan Miguel
Text and Data Mining valid from 2024-04-15
Version of Record valid from 2024-04-15
Article History
Received: 14 March 2024
Accepted: 27 March 2024
First Online: 15 April 2024
Declarations
:
: The authors declare no competing interests.
: The authors have no relevant financial or non-financial interests to disclose.